Regulatory T-Cell Levels in the Longest Surviving Asian Patient After Heart-Lung Transplant.

Abstract

Heart-lung transplant is the most effective therapy for patients with end-stage cardiopulmonary disease. Here, we report an initial assessment of a 31-year-old man who had survived more than 11 years after heart-lung transplant, which represents the longest survival time in this procedure in Asian studies. At his 11th anniversary after transplant, extensive… (More)
DOI: 10.6002/ect.2016.0351

Topics

Cite this paper

@article{Huang2017RegulatoryTL, title={Regulatory T-Cell Levels in the Longest Surviving Asian Patient After Heart-Lung Transplant.}, author={Lei Huang and Ming Ji and Shounan Yi and Xinmin Zhou}, journal={Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation}, year={2017} }